CRNA — Circio Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK2.89bn
- NOK2.36bn
Brief: Targovax Q4 Net Loss NOK 22.2 Million
Brief: Targovax Says Financing Of Up To NOK 300 Mln Over Three Years To Advance Its Clinical Cancer Programs & Pre-Clinical Circular RNA Platform
Brief: Targovax Announces Clinical Trial Collaboration With Agenus
Brief: Targovax Q3 Net Loss Narrows To NOK 20.7 Mln
Brief: Targovax Receives FDA Approval
Brief: Targovax Q2 Operating Loss Widens To NOK 30.7 Million
Brief: Targovax Gets FDA Authorization To Initiate Clinical Trials In USA
Agenus rises on new drug development collaborations
Brief: Targovax Q1 Net Loss Widens To NOK 30.4 Million
Brief: Targovax Announces Clinical Collaboration With Agenus For Upcoming Oncos-102 Phase 2 Melanoma Trial
Brief: Targovax To Collaborate With Oslo University Hospital On TG01 Test IN PHASE 1/2 TRIAL
Brief: Targovax Says Board Signed Joint Demerger And Merger Plan For Transfer Of Operational Activities Of Co To Its Unit Targovax Solution
Brief: Targovax ASA And Agenus Announce Collaboration On Mutant KRAS Cancer Vaccine Adjuvanted With QS-21 STIMULON™
Brief: Targovax And Agenus Announce Collaboration On Mutant Kras Cancer
Brief: Targovax ASA Says Exercise Of Options Under Lti Program, Settlement Of Rsus And Resolution To Increase The Share Capital
Brief: Targovax Appoints Dr. Lubor Gaal As CFO
Brief: Targovax Q4 Net Loss At NOK 26.6 Mln
Brief: Targovax And Prof. Michael Uhlin Enter Research Collaboration
Brief: Targovax Granted Patents For ONCOS-102 In China, Japan